Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

NCT07505836 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1040

Enrollment

INDUSTRY

Sponsor class

Conditions

Epidemic Meningitis
Meningococcal Vaccines

Interventions

BIOLOGICAL: experimental vaccine
BIOLOGICAL: Active Comparator vaccine

Sponsor

Sinovac Biotech Co., Ltd